Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Retained Earnings (2020 - 2026)

Cytek Biosciences filings provide 6 years of Retained Earnings readings, the most recent being -$101.7 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 635962.5% to -$101.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$101.7 million, a 635962.5% decrease, with the full-year FY2025 number at -$101.7 million, down 635962.5% from a year prior.
  • Retained Earnings hit -$101.7 million in Q4 2025 for Cytek Biosciences, down from -$57.7 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $897000.0 in Q4 2021 to a low of -$101.7 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$18.4 million (2021), compared with a mean of -$19.2 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 1280.0% in 2021 and later tumbled 635962.5% in 2025.
  • Cytek Biosciences' Retained Earnings stood at $897000.0 in 2021, then plummeted by 177.7% to -$697000.0 in 2022, then plummeted by 4086.23% to -$29.2 million in 2023, then skyrocketed by 100.05% to $16000.0 in 2024, then tumbled by 635962.5% to -$101.7 million in 2025.
  • The last three reported values for Retained Earnings were -$101.7 million (Q4 2025), -$57.7 million (Q3 2025), and -$38000.0 (Q2 2025) per Business Quant data.